Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

257 (7%)

Anticipated shortage:

3 (0%)

Avoided shortage:

11 (0%)

Resolved:

3300 (92%)

3571

Discontinuation Reports

To be discontinued:

24 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

366

143 (4%)

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DEFERASIROX (TYPE J) 360MG TABLET Resolved 2020-12-11 2021-01-20 130040
APO-DEFERASIROX (TYPE J) 90MG TABLET Resolved 2021-01-08 2021-01-20 131151
APO-DEFERASIROX (TYPE J) 360MG TABLET Resolved 2021-12-03 2021-12-20 150432
APO-DESMOPRESSIN 0.1MG TABLET Resolved 2017-03-10 2017-05-13 275
APO-DESMOPRESSIN 0.2MG TABLET Resolved 2017-07-24 2018-08-15 16683
APO-DESMOPRESSIN 0.1MG TABLET Resolved 2017-05-24 2017-06-21 11059
APO-DESMOPRESSIN 0.2MG TABLET Resolved 2024-12-05 2025-01-31 244883
APO-DESMOPRESSIN 0.2MG TABLET Resolved 2017-03-10 2017-06-21 278
APO-DESMOPRESSIN 0.1MG TABLET Resolved 2017-07-24 2017-12-20 16680
APO-DESMOPRESSIN 0.2MG TABLET Resolved 2024-09-20 2024-11-01 238230
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-08 2020-07-18 119759
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-09-16 92019
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-14 2022-02-18 152761
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-21 2018-03-08 40336
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-03-27 2018-07-03 44102
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2025-11-13 2026-01-03 271859
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-06 2018-07-03 38815
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-30 2021-06-07 138340
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2020-09-17 2020-10-08 124344
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-16 2018-10-02 55836
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE TABLETS 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-FLUVOXAMINE TABLETS 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971